Esperion Therapeutics | L'Utile Ante Imposte

Pre Tax Profit Cambiamento Data
AbbVie USD 5.99B 243M 2023-12
Alnylam Pharmaceuticals USD -137687000 288.43M 2023-12
Amarin USD -18810000 895K 2023-09
Amgen USD 3.03B 153M 2023-12
Cipla INR 15.94B 2.2B 2023-09
CSL USD 699.7M 1.26B 2023-06
Cytokinetics USD -136896000 7.47M 2023-12
Eli Lilly USD 2.59B 2.27B 2023-12
Geron USD -51973000 7.17M 2023-12
Halozyme Therapeutics USD 122.27M 894K 2023-09
Intra Cellular Therapies USD -28131000 3.92M 2023-12
Ionis Pharmaceuticals USD -3000000 138M 2023-12
Moderna USD 70M 2.03B 2023-12
Pfizer USD -1250000000 5.38B 2023-09
Regeneron Pharmaceuticals USD 1.4B 54.4M 2023-12
Sanofi EUR 3.96B 1.2B 2023-09
Sarepta Therapeutics USD -33174000 18.59M 2023-09
United Therapeutics USD 295.4M 56.4M 2023-12



Esperion Therapeutics L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.